GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Heart Test Laboratories Inc (NAS:HSCS) » Definitions » Altman Z-Score

Heart Test Laboratories (Heart Test Laboratories) Altman Z-Score : -8.62 (As of Jun. 23, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Heart Test Laboratories Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Warning Sign:

Altman Z-score of -8.62 is in distress zone. This implies bankruptcy possibility in the next two years.

Heart Test Laboratories has a Altman Z-Score of -8.62, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Heart Test Laboratories's Altman Z-Score or its related term are showing as below:

HSCS' s Altman Z-Score Range Over the Past 10 Years
Min: -46.31   Med: -26.76   Max: -6.92
Current: -8.62

During the past 4 years, Heart Test Laboratories's highest Altman Z-Score was -6.92. The lowest was -46.31. And the median was -26.76.


Heart Test Laboratories Altman Z-Score Historical Data

The historical data trend for Heart Test Laboratories's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heart Test Laboratories Altman Z-Score Chart

Heart Test Laboratories Annual Data
Trend Apr20 Apr21 Apr22 Apr23
Altman Z-Score
- - - -29.93

Heart Test Laboratories Quarterly Data
Apr20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -26.76 -29.93 -39.26 -46.31 -6.92

Competitive Comparison of Heart Test Laboratories's Altman Z-Score

For the Medical Devices subindustry, Heart Test Laboratories's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Heart Test Laboratories's Altman Z-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Heart Test Laboratories's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Heart Test Laboratories's Altman Z-Score falls into.



Heart Test Laboratories Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Heart Test Laboratories's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.6467+1.4*-6.0657+3.3*-0.5578+0.6*1.5644+1.0*0.0018
=-8.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Jan. 2024:
Total Assets was $10.80 Mil.
Total Current Assets was $8.69 Mil.
Total Current Liabilities was $1.71 Mil.
Retained Earnings was $-65.52 Mil.
Pre-Tax Income was -1.644 + -1.748 + -1.367 + -1.632 = $-6.39 Mil.
Interest Expense was -0.118 + -0.178 + -0.036 + -0.034 = $-0.37 Mil.
Revenue was 0.015 + 0.004 + 0 + 0 = $0.02 Mil.
Market Cap (Today) was $3.39 Mil.
Total Liabilities was $2.17 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(8.691 - 1.706)/10.801
=0.6467

X2=Retained Earnings/Total Assets
=-65.516/10.801
=-6.0657

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-6.391 - -0.366)/10.801
=-0.5578

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=3.390/2.167
=1.5644

X5=Revenue/Total Assets
=0.019/10.801
=0.0018

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Heart Test Laboratories has a Altman Z-Score of -8.62 indicating it is in Distress Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


Heart Test Laboratories  (NAS:HSCS) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Heart Test Laboratories Altman Z-Score Related Terms

Thank you for viewing the detailed overview of Heart Test Laboratories's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Heart Test Laboratories (Heart Test Laboratories) Business Description

Traded in Other Exchanges
N/A
Address
550 Reserve Street, Suite 360, Southlake, TX, USA, 76092
Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings.
Executives
David R. Wells director 2801 OCEAN PARK BLVD., SUITE 339, SANTA MONICA CA 90405
Bruce Bent director 750 BONHAM PARKWAY, LANTANA TX 76226
Mark T Hilz director, officer: See Remarks 3301 DAKOTA DRIVE, NORTHLAKE TX 76226
Patrick Kanouff director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Brian Szymczak director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Danielle Watson officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Andrew Simpson director, officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092

Heart Test Laboratories (Heart Test Laboratories) Headlines

From GuruFocus

HeartSciences Announces Further Internationalization of its Patent Portfolio

By Stock market mentor Stock market mentor 02-03-2023